These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3161533)

  • 1. The effects of the administration of tamoxifen, ethynyloestradiol, and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo.
    Deshpande N; Mitchell I; Maltinti M; Boi A; Di Martino L
    Br J Cancer; 1985 Aug; 52(2):241-4. PubMed ID: 3161533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug effects on certain enzymes of carbohydrate metabolism in MCF-7 cells in culture.
    Mitchell I; Deshpande N
    Clin Oncol; 1984 Sep; 10(3):253-60. PubMed ID: 6236924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of opiates and naloxone on certain enzymes of carbohydrate metabolism in human breast carcinomas.
    Di Martino L; Tarquini A; Mitchell I; Deshpande N
    Tumori; 1982 Oct; 68(5):397-401. PubMed ID: 6294937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: a preliminary report.
    DiMartino L; Demontis B; Mitchell IP; Hayward SW; Deshpande N
    Anticancer Res; 1991; 11(2):869-72. PubMed ID: 2064345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme studies in human prostatic tissues.
    Deshpande N; Mitchell I; Towler J
    Clin Oncol; 1983 Mar; 9(1):25-30. PubMed ID: 6189658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme studies in human transitional cell carcinoma of the urinary bladder.
    Mitchell I; Hayward S; Deshpande N; Towler JM
    J Urol; 1989 May; 141(5):1234-7. PubMed ID: 2523490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour enzymes and prognosis in human breast cancer.
    Deshpande N; Mitchell I; Millis R
    Eur J Cancer (1965); 1981 Apr; 17(4):443-8. PubMed ID: 6458498
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of tamoxifen pre-treatment on the retention of tritiated oestradiol and 5alpha-dihydrotestosterone and on glucose metabolism in human breast carcinomas.
    Deshpande N; Mitchell I; Hughes D
    Eur J Cancer (1965); 1978 May; 14(5):473-7. PubMed ID: 148360
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
    Fentiman IS; Howell A; Hamed H; Lee SM; Ranson M; Wall J; Chaudary MA; Ash CM; Gregory WM; Sellwood RA
    Br J Cancer; 1994 Oct; 70(4):729-31. PubMed ID: 7917929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of training on the activity of five muscle enzymes studied on elite cross-country skiers.
    Evertsen F; Medbo JI; Jebens E; Gjøvaag TF
    Acta Physiol Scand; 1999 Nov; 167(3):247-57. PubMed ID: 10606827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.
    Bontenbal M; Foekens JA; Lamberts SW; de Jong FH; van Putten WL; Braun HJ; Burghouts JT; van der Linden GH; Klijn JG
    Br J Cancer; 1998; 77(1):115-22. PubMed ID: 9459155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
    Jakesz R; Hausmaninger H; Haider K; Kubista E; Samonigg H; Gnant M; Manfreda D; Tschurtschenthaler G; Kolb R; Stierer M; Fridrik M; Mlineritsch B; Steindorfer P; Mittlböck M; Steger G
    J Clin Oncol; 1999 Jun; 17(6):1701-9. PubMed ID: 10561206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
    Bièche I; Girault I; Urbain E; Tozlu S; Lidereau R
    Breast Cancer Res; 2004; 6(3):R252-63. PubMed ID: 15084249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
    Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
    Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.
    International Breast Cancer Study Group
    J Clin Oncol; 1997 Apr; 15(4):1385-94. PubMed ID: 9193330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
    Uchino J; Samejima N; Tanabe T; Hayasaka H; Mito M; Hata Y; Asaishi K
    Br J Cancer; 1994 Apr; 69(4):767-71. PubMed ID: 8142265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
    Locker GY; Sainsbury JR; Cuzick J;
    Cancer; 2004 Aug; 101(4):735-40. PubMed ID: 15305403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.